Medical device company Artivion (NYSE:AORT) reported Q3 CY2025 results exceeding the market’s revenue expectations, with ...

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the ...

If you have wider feet you know how uncomfortable it can be to wear traditional shoes. It results in calluses, corns, and ...